Skip to content

Neonatal Warming to Prevent Hypothermia

Preventing Hypothermia in Moderate and Late Preterm Neonates - a Pilot Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04827394
Enrollment
52
Registered
2021-04-01
Start date
2020-12-01
Completion date
2023-02-21
Last updated
2024-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypothermia

Brief summary

Researchers are proposing a pilot randomized controlled trial evaluating the benefit of immediately warming preterm babies using a warming mattress and a plastic wrap, while delaying clamping the umbilical cord at the time of c-section in babies born between 32 and 36 weeks to determine if it reduces the risk of hypothermia.

Detailed description

The trial will be advertised and introduced to patients admitted to the OU Children's Hospital labor and delivery or antepartum units by research nurses. Interested participants will be consented. Researchers are choosing to only include patients undergoing non-emergent cesarean in order to improve their ability to control parameters such as room temperature and labor-related clinical or subclinical maternal infection, which are known confounders. Further, they are limiting their investigation to fetuses 32-36 weeks gestation, since this population represents the largest preterm delivery population. Recruitment and randomization will be stratified by gestational age with an aim to enroll at least 44 pregnancies at 32-34 weeks and 6 days and 20 pregnancies between 35-36 weeks and 6 days. Last, it is impossible to recruit patients outside of the inpatient setting for a study investigating preterm delivery, as such deliveries are rarely predictable in the outpatient setting. There will only be one site for this study, the OU Children's Hospital labor and delivery and antepartum units. The proposed study is a pragmatic randomized controlled pilot trial of neonatal warming techniques with participants allocated in a 1:1 ratio using a random block allocation table using blocks of size 4 and 6 that are stratified by gestational age ranges of 35-36 weeks and 6 days and 32-34 weeks and 6 days. Since there cannot be a placebo intervention, neither the patient nor the neonatal team will be blinded to the group assignment. The group assignments will be made and coded by a third party at the time of randomization. Patients will be randomized to their respective groups immediately prior to surgery. The surgical technician will be provided with the necessary neonatal wraps and mattresses in a sterile fashion, and they will ensure these are available on the surgical field once the cesarean has begun. In the intervention group, the thermal mattress will be activated immediately prior to hysterotomy and placed on the sterile field with delivery of the infant directly onto the mattress. The infant will be dried, stimulated and bulb suctioned as deemed necessary per standard of care followed by wrapping. In the non-intervention group, the infant will be delivered onto the sterile field, dried and suctioned as deemed necessary per OU standard. Cord clamping will be delayed for 60 seconds in all infants under the supervision of both the obstetrician and the neonatal resuscitation team. If either team believes delayed cord clamping is no longer considered safe, as is usual protocol, the cord will be clamped and cut and the baby will be handed off to the neonatology team. After the infant is handed to the neonatology team along with all group assignment specific materials (neonatal wrap and thermal mattress, if in the intervention group), neonatal temperature will be assessed immediately upon arrival to the resuscitation warmer using a digital thermometer placed in the axillary space. Infant temperature will be recorded at 1) arrival to the warmer, 2) after the neonatologist deems that in-room resuscitation is complete and 3) at admission to the Neonatal Intensive Care Unit (NICU), Mother Baby Unit (MBU) or Post-Anesthesia Care Unit (PACU) depending on the baby's needs; determined by the resuscitating physicians. These measurements will be recorded by research nurses in a data collection sheet. Further, the research nurse will record the time from delivery to the time it takes for the infant to arrive at the warmer. Upon arrival at the warmer, the mattress and wrap will be removed as neonatal evaluation takes place. As immediate neonatal temperature is not generally discussed with patients unless there is an issue such as concern for infection, neonatal temperature will not be routinely discussed with all participants. Only if there is concern for neonatal infection or if there is hyperthermia (\>37.5 degrees C) will the study results be discussed with the patient.

Interventions

DEVICENeonatal warming mattress

Babies will be warmed with a standard neonatal transport warming mattress immediately after birth.

DEVICESterile polyethylene wrap

Babies will be wrapped in a sterile polyethylene wrap prior to arrival at the warmer.

Sponsors

University of Oklahoma
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

1:1 using a block randomization scheme stratified by gestational age

Eligibility

Sex/Gender
FEMALE
Age
No minimum to 55 Years
Healthy volunteers
No

Inclusion criteria

* Patients who have non-emergent cesarean deliveries (defined as at least 2 hours prior to planned cesarean) * Gestational age between 32 weeks and 0 days and 36 weeks and 6 days determined per usual clinical parameters

Exclusion criteria

* Fetal anomalies or death * Maternal diabetes * Neonates with blistering skin conditions * Reversed end diastolic umbilical artery flow * Placental abruption * Chorioamnionitis * Monochorionic multifetal pregnancies * Inability to provide consent * Provider perception that patient is in significant pain and provider perceived contraindications to delayed cord clamping.

Design outcomes

Primary

MeasureTime frameDescription
Temperature at Arrival to Warmer3 minutesTemperature at arrival to the Warmer

Secondary

MeasureTime frameDescription
Temperature at NICU/Recovery24 hoursTemperature at admission to NICU/Recovery
Peak BilirubinThrough hospital discharge up to 3 monthsHighest bilirubin level of infant based on blood test
Duration of Respiratory SupportThrough hospital discharge up to 3 monthsDuration of respiratory support in the form of intubation or continuous positive airway pressure (if applicable)
Length of Delayed Cord ClampUp to 60 seconds after birthLength of delayed cord clamp in seconds
Length of Hospital StayThrough hospital discharge up to 3 monthsLength of hospital stay in days
Age to Wean to CribThrough hospital discharge up to 3 monthsAge to wean to crib in days
Temperature at Exit3 minutesThe temperature at exit is only available for n=21 in treatment groups and n=19 in control group.
Hypothermia at Completion of ResuscitationThrough hospital discharge up to 3 monthsHypothermia at the Completion of Resuscitation
Hypothermia at NICU/RecoveryThrough hospital discharge up to 3 monthsHypothermia at NICU admission /Recovery
Hyperthermia (>37.5C) at WarmerThrough hospital discharge up to 3 monthsHyperthermia (\>37.5C) at arrival to Warmer
Hypoglycemia24 hoursHypoglycemia (less than 30mg/dL in the first 24 hours)
Need for NICU Admission24 hoursWhether or not infant was admitted to NICU
CompositeThrough hospital discharge up to 3 monthsComposite neonatal morbidity (if applicable)
Hypothermia at WarmerImmediately after cord clamping (up to 60 seconds after birth)Number of infants with hypothermia at time of arrival to warmer

Countries

United States

Participant flow

Pre-assignment details

The values reported reflect the total number of unique participants (mothers) assigned to each Arm.

Participants by arm

ArmCount
Intervention Group
In the intervention group, the infant will be placed on the thermal mattress, then wrapped. Neonatal warming mattress: Babies will be warmed with a standard neonatal transport warming mattress immediately after birth. Sterile polyethylene wrap: Babies will be wrapped in a sterile polyethylene wrap prior to arrival at the warmer.
25
Control Group
In the non-intervention group, the infant will be delivered onto the sterile field as per standard of care.
25
Total50

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyPhysician Decision02

Baseline characteristics

CharacteristicTotalIntervention GroupControl Group
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
50 Participants25 Participants25 Participants
Body Mass Index (kg/m2)33.35 kg/m234.2 kg/m232.5 kg/m2
Fetal Complications
Death
0 participants0 participants0 participants
Fetal Complications
Fetal Growth Restriction
5 participants1 participants4 participants
Fetal Complications
Oligohydramnios
3 participants1 participants2 participants
Fetal Complications
Polyhydramnios
1 participants1 participants0 participants
Fetal Complications
Sepsis
2 participants1 participants1 participants
Fetal Complications
Twins
6 participants3 participants3 participants
Gestational age241.6 days
STANDARD_DEVIATION 11
241.0 days
STANDARD_DEVIATION 10.8
242.1 days
STANDARD_DEVIATION 11.1
Maternal Age30.3 years
STANDARD_DEVIATION 6.3
31.9 years
STANDARD_DEVIATION 6.4
28.7 years
STANDARD_DEVIATION 6.2
Maternal Complications
Chronic Hypertension
16 participants10 participants6 participants
Maternal Complications
Eclampsia
0 participants0 participants0 participants
Maternal Complications
Gestational Hypertension
4 participants2 participants2 participants
Maternal Complications
HELLP
0 participants0 participants0 participants
Maternal Complications
None
6 participants3 participants3 participants
Maternal Complications
Preeclampsia Without Severe Features
3 participants0 participants3 participants
Maternal Complications
Preeclampsia With Severe Features
18 participants8 participants10 participants
Maternal Complications
Thyroid Disorder
2 participants0 participants2 participants
Maternal Labor12 participants5 participants7 participants
Meconium Stain0 participants0 participants0 participants
NICU Admission34 participants16 participants18 participants
Number of prenatal visits6.6 visits
STANDARD_DEVIATION 3.2
6.5 visits
STANDARD_DEVIATION 3
6.6 visits
STANDARD_DEVIATION 3.3
Payor Status
Government/Self
29 participants14 participants15 participants
Payor Status
Private
21 participants11 participants10 participants
Race/Ethnicity, Customized
American Indian/Alaska Native
3 Participants2 Participants1 Participants
Race/Ethnicity, Customized
Asian
1 Participants0 Participants1 Participants
Race/Ethnicity, Customized
Black or African American
4 Participants2 Participants2 Participants
Race/Ethnicity, Customized
Ethnicity Unknown or Not Reported
7 Participants4 Participants3 Participants
Race/Ethnicity, Customized
Hispanic or Latino
11 Participants4 Participants7 Participants
Race/Ethnicity, Customized
Not Hispanic or Latino
32 Participants17 Participants15 Participants
Race/Ethnicity, Customized
Unknown/Not Reported
12 Participants5 Participants7 Participants
Race/Ethnicity, Customized
White
30 Participants16 Participants14 Participants
Recevied Prenatal Care46 participants23 participants23 participants
Rupture of Membranes20 participants8 participants12 participants
Sex: Female, Male
Female
50 Participants25 Participants25 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 250 / 251 / 251 / 25
other
Total, other adverse events
0 / 250 / 252 / 251 / 25
serious
Total, serious adverse events
0 / 250 / 250 / 250 / 25

Outcome results

Primary

Temperature at Arrival to Warmer

Temperature at arrival to the Warmer

Time frame: 3 minutes

ArmMeasureValue (MEDIAN)
Intervention GroupTemperature at Arrival to Warmer36.9 degrees Celsius
Control GroupTemperature at Arrival to Warmer37.0 degrees Celsius
Secondary

Age to Wean to Crib

Age to wean to crib in days

Time frame: Through hospital discharge up to 3 months

ArmMeasureValue (MEDIAN)
Intervention GroupAge to Wean to Crib3.0 days
Control GroupAge to Wean to Crib1.0 days
Secondary

Composite

Composite neonatal morbidity (if applicable)

Time frame: Through hospital discharge up to 3 months

ArmMeasureValue (NUMBER)
Intervention GroupComposite1 participants
Control GroupComposite1 participants
Secondary

Duration of Respiratory Support

Duration of respiratory support in the form of intubation or continuous positive airway pressure (if applicable)

Time frame: Through hospital discharge up to 3 months

ArmMeasureValue (MEDIAN)
Intervention GroupDuration of Respiratory Support114.3 hours
Control GroupDuration of Respiratory Support31.2 hours
Secondary

Hyperthermia (>37.5C) at Warmer

Hyperthermia (\>37.5C) at arrival to Warmer

Time frame: Through hospital discharge up to 3 months

ArmMeasureValue (NUMBER)
Intervention GroupHyperthermia (>37.5C) at Warmer2 participants
Control GroupHyperthermia (>37.5C) at Warmer1 participants
Secondary

Hypoglycemia

Hypoglycemia (less than 30mg/dL in the first 24 hours)

Time frame: 24 hours

ArmMeasureValue (NUMBER)
Intervention GroupHypoglycemia4 participants
Control GroupHypoglycemia3 participants
Secondary

Hypothermia at Completion of Resuscitation

Hypothermia at the Completion of Resuscitation

Time frame: Through hospital discharge up to 3 months

ArmMeasureValue (NUMBER)
Intervention GroupHypothermia at Completion of Resuscitation6 participants
Control GroupHypothermia at Completion of Resuscitation3 participants
Secondary

Hypothermia at NICU/Recovery

Hypothermia at NICU admission /Recovery

Time frame: Through hospital discharge up to 3 months

ArmMeasureValue (NUMBER)
Intervention GroupHypothermia at NICU/Recovery7 participants
Control GroupHypothermia at NICU/Recovery11 participants
Secondary

Hypothermia at Warmer

Number of infants with hypothermia at time of arrival to warmer

Time frame: Immediately after cord clamping (up to 60 seconds after birth)

ArmMeasureValue (NUMBER)
Intervention GroupHypothermia at Warmer6 participants
Control GroupHypothermia at Warmer2 participants
Secondary

Length of Delayed Cord Clamp

Length of delayed cord clamp in seconds

Time frame: Up to 60 seconds after birth

ArmMeasureValue (MEDIAN)
Intervention GroupLength of Delayed Cord Clamp61.0 seconds
Control GroupLength of Delayed Cord Clamp62.0 seconds
Secondary

Length of Hospital Stay

Length of hospital stay in days

Time frame: Through hospital discharge up to 3 months

ArmMeasureValue (MEDIAN)
Intervention GroupLength of Hospital Stay11.0 days
Control GroupLength of Hospital Stay7.0 days
Secondary

Need for NICU Admission

Whether or not infant was admitted to NICU

Time frame: 24 hours

ArmMeasureValue (NUMBER)
Intervention GroupNeed for NICU Admission16 participants
Control GroupNeed for NICU Admission18 participants
Secondary

Peak Bilirubin

Highest bilirubin level of infant based on blood test

Time frame: Through hospital discharge up to 3 months

ArmMeasureValue (MEDIAN)
Intervention GroupPeak Bilirubin9.0 mg/dl
Control GroupPeak Bilirubin9.0 mg/dl
Secondary

Temperature at Exit

The temperature at exit is only available for n=21 in treatment groups and n=19 in control group.

Time frame: 3 minutes

ArmMeasureValue (MEDIAN)
Intervention GroupTemperature at Exit36.8 degrees Celsius
Control GroupTemperature at Exit36.7 degrees Celsius
Secondary

Temperature at NICU/Recovery

Temperature at admission to NICU/Recovery

Time frame: 24 hours

ArmMeasureValue (MEDIAN)
Intervention GroupTemperature at NICU/Recovery36.6 degrees Celsius
Control GroupTemperature at NICU/Recovery36.5 degrees Celsius

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026